iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-78.73M -34.61M -43.71M -45.36M -7.13M -38.22M -30.55M -32.24M -34.3M -15.55M 20.45M 991K 5.63M 69.58M 184.87M 69.64M -26.46M -13.53M
Depreciation & Amortization
340K 324K 324K 302K 309K 303K 227K 224K 225K 222K 223K 205K 195K 180K 151K 176K 150K 126K
Stock-Based Compensation
5.88M 6.63M 7.07M 7.54M 8.06M 7.26M 7.19M 7.06M 6.96M 5.81M 5.88M 5.72M 5.76M 4.19M 4.04M 3.94M 3.23M 2.58M
Other Working Capital
40.59M -47.66M 8.09M 6.17M -367K 6.16M 3.94M -4.2M 509K -13.83M -49.37M -35.57M -42.89M -103.42M -248.4M 537.74M -1.09M -6.32M
Other Non-Cash Items
-2.63M 768K -6.59M -31.23M -2.79M -2.74M -2.19M -2.66M -2.54M -2.85M -1.73M 3K 2K 2K 2K 2K 2K 6K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
32.69M -6.88M 48.4M 31.39M -32.38M 990K 11.55M -6.27M 101K -14.18M -52.01M -36.62M -41.91M -97.96M -247.88M 531.24M 4.83M -3.97M
Operating Cash Flow
-42.45M -33.76M 5.5M -37.35M -33.93M -32.4M -13.77M -33.89M -29.55M -26.55M -27.17M -29.7M -30.32M -24M -58.82M 605M -18.25M -14.79M
Capital Expenditures
-283K -101K -152K -94K -442K -945K -1.4M -751K -700K -119K -117K -83K -511K -227K -162K -530K -401K -88K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -20.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-29.65M -60.34M -80.2M -195.52M -89.22M -155.85M -97.03M -54.47M -86.46M -52.58M -445K n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
116.89M 108.16M 94M 104.13M 105.98M 87.2M 160M 78M 107.27M 21M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-2K -24K -25K n/a n/a n/a n/a -83K 20.8M n/a -444.56M -22K -3K -96K 1K -2K -57K -3K
Investing Cash Flow
86.95M 47.69M 13.62M -91.49M 16.32M -69.6M 61.56M 22.69M 20.1M -31.69M -445.12M -105K -514K -323K -161K -532K -458K -91K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.49M n/a 11K -211K n/a n/a n/a n/a 218K 578K 1.37M n/a 278K 333K 2.36M 441K 195K 667K
Financial Cash Flow
4.49M 32K 285K -442K 122.38M 22K 307K 10K 218K 578K 1.37M -1K 278K 333K 2.36M 441K 195K 667K
Net Cash Flow
51.29M 14.42M 18.38M -127.05M 104.45M -104.53M 47.05M -12.08M -9.11M -59.44M -467.43M -39.68M -32.13M -24.55M -51.07M 596.83M -18.45M -14.93M
Free Cash Flow
-42.73M -33.87M 5.34M -37.45M -34.37M -33.34M -15.16M -34.64M -30.25M -26.67M -27.29M -29.78M -30.83M -24.23M -58.98M 604.47M -18.66M -14.88M